Contents

Current Cancer Drug Targets, Volume 17 - Number 4

Biography

Meet Our Editorial Board Member

, 17(4): 303

Thomas W. Grunt


DOI: 10.2174/156800961704170419204900




Review Article

Synthetic Lethal Interactions in Cancer Therapy

, 17(4): 304 - 310

Xinwei Geng, Xiaohui Wang, Dan Zhu and Songmin Ying


DOI: 10.2174/1568009616666160426122736





Review Article

Chemotherapy and Cardiotoxicity in Hematologic Malignancies

, 17(4): 311 - 324

Antonio Stellitano, Roberta Fedele, Santina Barilla, Antonino Iaria, Carmelo Massimiliano Rao and Massimo Martino


DOI: 10.2174/1568009617666161121141607





Review Article

The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer

, 17(4): 325 - 332

Vladimir Stanislavovich Rogovskii


DOI: 10.2174/1568009617666170109110816





Review Article

New Candidate Genes for Lack of Sensitivity to Therapy in Pediatric Leukemias

, 17(4): 333 - 343

Weronika Bereza, Joanna Szczepanek, Joanna Laskowska and Andrzej Tretyn


DOI: 10.2174/1568009616666161208150148





Review Article

Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-therapy

, 17(4): 344 - 356

Heena Singla, Sourav Kalra, Preeti Kheterpal, Vinod Kumar and Anjana Munshi


DOI: 10.2174/1568009616666161216094026





Review Article

Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials

, 17(4): 357 - 375

Bhupinder Kumar, Rakesh Kumar, Ira Skvortsova and Vinod Kumar


DOI: 10.2174/1568009616666160928110818





Research Article

Polyphyllin II Restores Sensitization of the Resistance of PC-9/ZD Cells to Gefitinib by a Negative Regulation of the PI3K/Akt/mTOR Signaling Pathway

, 17(4): 376 - 385

Ruzhen Zheng, Hao Jiang, Jinhui Li, Xinge Liu and Hongwei Xu


DOI: 10.2174/1568009616666161213141608





Research Article

Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells

, 17(4): 386 - 401

Qiaohua Zhu, Xinfa Yu, Zhi-Wei Zhou, Chengyu Zhou, Xiao-Wu Chen and Shu-Feng Zhou


DOI: 10.2174/1568009616666160630182344





Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science